Thompson Peter A. — SEC insider filings

SEC reporting owner CIK 1357522. 71 insider filings on record with FilingPulse; latest filed 2026-11-04.

Transaction summary — filings shown

Covers the 50 most recent of 71 filings on record, filed 2022-01-04 to 2026-11-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Sionna Therapeutics, Inc. (SION)Director131 leg · 550,000 sh · $9,900,00020 legs · 1,235,000 sh · $55,674,6365
ALPINE IMMUNE SCIENCES, INC. (ALPN)Director6—6 legs · 1,546,347 sh · $28,671,73414
Edgewise Therapeutics, Inc. (EWTX)Director, 10% owner95 legs · 1,573,812 sh · $20,994,974—5
ARS Pharmaceuticals, Inc. (SPRY)Director81 leg · 500,000 sh · $3,100,0005 legs · 952,377 sh · $12,585,9985
Aspen Neuroscience, Inc. (ASPE)Director, 10% owner21 leg · 1,000,000 sh · $15,000,000—10
Corvus Pharmaceuticals, Inc. (CRVS)Director, 10% owner10—1 leg · 1,176,332 sh · $4,891,89437
Decibel Therapeutics, Inc. (DBTX)Director, 10% owner1——1
Janux Therapeutics, Inc. (JANX)Director1——1

Insider filings — Thompson Peter A.

FiledFormIssuerReported transactionsSource
2026-11-044Aspen Neuroscience, Inc. (ASPE)Conversion (C): 196,541 · Conversion (C): 642,745 · Conversion (C): 616,984 · Conversion (C): 625,743 · Conversion (C): 507,119 · Purchase (P): 1,000,000 @ $15 · +5 moreEDGAR
2026-10-293Aspen Neuroscience, Inc. (ASPE)Holdings only — no transactions reportedEDGAR
2026-07-094Sionna Therapeutics, Inc. (SION)Sale (S): 85,918 @ $44.86EDGAR
2026-07-024Sionna Therapeutics, Inc. (SION)Sale (S): 115,844 @ $45.50EDGAR
2026-06-264ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2026-06-184Sionna Therapeutics, Inc. (SION)Grant/award (A): 17,340 (derivative) @ $0EDGAR
2026-06-174Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 16,377 (derivative) @ $0EDGAR
2026-06-154Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2026-05-294Sionna Therapeutics, Inc. (SION)Sale (S): 101 @ $44.49EDGAR
2026-05-114Sionna Therapeutics, Inc. (SION)Sale (S): 48,546 @ $44.61 · Sale (S): 59,767 @ $44.58 · Sale (S): 184,639 @ $46.22EDGAR
2026-04-214Sionna Therapeutics, Inc. (SION)Sale (S): 52,397 @ $44.68 · Sale (S): 2,948 @ $44.52EDGAR
2026-04-164Sionna Therapeutics, Inc. (SION)Sale (S): 47,814 @ $44.51 · Sale (S): 235,863 @ $44.64 · Sale (S): 226,906 @ $45.34EDGAR
2026-02-044Sionna Therapeutics, Inc. (SION)Sale (S): 1,890 @ $44.57 · Sale (S): 29,063 @ $44.58EDGAR
2026-01-304Corvus Pharmaceuticals, Inc. (CRVS)Option exercise (M): 30,000 @ $15 · Option exercise (M): 15,000 @ $9.70 · Option exercise (M): 15,000 @ $12.50 · Option exercise (M): 15,000 @ $3.61 · Option exercise (M): 15,000 @ $2 · Option exercise (M): 15,000 @ $3.27 · +20 moreEDGAR
2025-12-294Sionna Therapeutics, Inc. (SION)Sale (S): 33,356 @ $44.55EDGAR
2025-12-194Sionna Therapeutics, Inc. (SION)Sale (S): 900 @ $44.50 · Sale (S): 100 @ $44.49 · Sale (S): 875 @ $44.49EDGAR
2025-11-264Sionna Therapeutics, Inc. (SION)Sale (S): 94,583 @ $44.54 · Sale (S): 11,890 @ $44.60 · Sale (S): 1,600 @ $44.49EDGAR
2025-07-014Corvus Pharmaceuticals, Inc. (CRVS)Option exercise/expiry (X): 1,397,684 @ $3.50 · Sale (S): 1,176,332 @ $4.16 · Option exercise/expiry (X): 1,397,684 (derivative) @ $0EDGAR
2025-06-274ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-184Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 30,000 (derivative) @ $0EDGAR
2025-06-164Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2025-06-164Sionna Therapeutics, Inc. (SION)Grant/award (A): 19,959 (derivative) @ $0EDGAR
2025-04-044Edgewise Therapeutics, Inc. (EWTX)Purchase (P): 372,578 @ $20.13 · Purchase (P): 124,193 @ $20.13EDGAR
2025-02-104Sionna Therapeutics, Inc. (SION)Conversion (C): 3,154,959 · Purchase (P): 550,000 @ $18 · Conversion (C): 2,560,951 (derivative) @ $0 · Conversion (C): 2,048,760 (derivative) @ $0EDGAR
2024-08-284ARS Pharmaceuticals, Inc. (SPRY)Sale (S): 83,695 @ $13EDGAR
2024-08-234ARS Pharmaceuticals, Inc. (SPRY)Sale (S): 394,400 @ $13.52 · Sale (S): 13,300 @ $14.61 · Sale (S): 391,482 @ $12.94 · Sale (S): 69,500 @ $13.03EDGAR
2024-06-244ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-06-174Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2024-06-124Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 20,594 (derivative) @ $0EDGAR
2024-05-204ALPINE IMMUNE SCIENCES, INC. (ALPN)Code (U): 2,416,181 · Code (U): 264,315 · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · Disposition to issuer (D): 7,650 (derivative) · +3 moreEDGAR
2024-05-084Corvus Pharmaceuticals, Inc. (CRVS)Purchase (P): 1,444,085 (derivative) @ $1.73 · Purchase (P): 1,397,684 (derivative)EDGAR
2024-01-254Edgewise Therapeutics, Inc. (EWTX)Purchase (P): 454,545 @ $11EDGAR
2024-01-164ALPINE IMMUNE SCIENCES, INC. (ALPN)Option exercise/expiry (X): 145,251 @ $12.74 · Option exercise/expiry (X): 145,251 (derivative) @ $0EDGAR
2024-01-044ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 17,500 (derivative) @ $0EDGAR
2023-12-294ALPINE IMMUNE SCIENCES, INC. (ALPN)Sale (S): 162,576 @ $19.96 · Sale (S): 18,922 @ $19.96 · Sale (S): 26,872 @ $19.82 · Sale (S): 3,128 @ $19.82 · Sale (S): 1,195,683 @ $18.32 · Sale (S): 139,166 @ $18.32EDGAR
2023-12-084Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-08-314ARS Pharmaceuticals, Inc. (SPRY)Purchase (P): 500,000 @ $6.20EDGAR
2023-06-284ARS Pharmaceuticals, Inc. (SPRY)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-06-204Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2023-06-144Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 22,123 (derivative) @ $0EDGAR
2023-01-054ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-09-164Edgewise Therapeutics, Inc. (EWTX)Purchase (P): 484,496 @ $10.32EDGAR
2022-08-154Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-284Edgewise Therapeutics, Inc. (EWTX)Grant/award (A): 42,087 (derivative) @ $0EDGAR
2022-06-214Decibel Therapeutics, Inc. (DBTX)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2022-06-174Corvus Pharmaceuticals, Inc. (CRVS)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2022-06-164Janux Therapeutics, Inc. (JANX)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2022-06-134Silverback Therapeutics, Inc. (SBTX)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2022-05-204Edgewise Therapeutics, Inc. (EWTX)Purchase (P): 138,000 @ $7.21EDGAR
2022-01-044ALPINE IMMUNE SCIENCES, INC. (ALPN)Grant/award (A): 10,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-09-28 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1357522 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs